Navy Approves Full Production Rate For CH-53K

Image: Lockheed Martin/Sikorsky
Gemini Sparkle

Key Takeaways:

  • Lockheed Martin subsidiary Sikorsky has received U.S. Navy authorization for full-rate production of the CH-53K King Stallion heavy lift helicopter.
  • This approval will increase production to over 20 helicopters annually, with manufacturing expected to continue through at least 2032.
  • The U.S. Marine Corps, which achieved initial operational capability last April, plans to acquire up to 200 of these aircraft.
  • CH-53K production supports a broad domestic supply chain, involving over 200 companies across 34 states.
See a mistake? Contact us.

Lockheed Martin subsidiary Sikorsky has announced that the U.S. Navy has authorized full-rate production of the CH-53K King Stallion heavy lift helicopter. According to the company, the approval will increase production to more than 20 helicopters a year. The model is expected to remain in production through at least 2032.

“Ramping up production of the most technologically advanced helicopter in the world allows the U.S. Marine Corps to build out its CH-53K King Stallion fleet and support mission success,” said Sikorsky CH-53K program director Bill Falk. “This production authorization stabilizes Sikorsky’s domestic supply chain and is a testament to our enduring partnership with the Marine Corps.”

The Marine Corps achieved initial operational capability (IOC) for the CH-53K last April and is expected to acquire up to 200 aircraft. Sikorsky has delivered a total of seven CH-53Ks to the Marine Corps to date. The company noted that its supplier network for CH-53K production includes more than 200 companies across 34 states.

Kate O'Connor

Kate is a private pilot, certificated aircraft dispatcher, and graduate of Embry-Riddle Aeronautical University.
Sign-up for newsletters & special offers!

Get the latest stories & special offers delivered directly to your inbox

SUBSCRIBE

Please support AVweb.

It looks like you’re using an ad blocker. Ads keep AVweb free and fund our reporting.
Please whitelist AVweb or continue with ads enabled.